ArticleBMC infectious diseases2021

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB).

Natasha F Sabur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.